Nautilus Biotechnolgy, Inc. (NAUT) — Financial statements
Income statement, balance sheet, and cash flow for Nautilus Biotechnolgy, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 6↑1.8% | 6↑11.4% | 6↑67.0% | 3↑20.2% | 3 | |
| Gross Profit | -6↓1.8% | -6↓11.4% | -6↓67.0% | -3↓20.2% | -3 | |
| Operating Expenses | ||||||
| R&D Expenses | 41↓18.6% | 50↑6.8% | 47↑29.6% | 36↑37.5% | 27 | |
| General & Administrative Expenses | 26↓17.0% | 31↑7.3% | 29 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 26↓17.0% | 31↑7.3% | 29↑21.7% | 24↑12.3% | 21 | |
| Other Expenses | -6↓1.8% | -6↓11.4% | -6 | 0.00 | 0.00 | |
| Operating Expenses | 60↓19.6% | 75↑6.6% | 70↑17.0% | 60↑26.3% | 48 | |
| Total Costs & Expenses | 67↓18.0% | 81↑7.0% | 76↑19.7% | 64↑26.0% | 50 | |
| Operating Results | ||||||
| Operating Income | -67↑18.0% | -81↓7.0% | -76↓19.7% | -64↓26.0% | -50 | |
| Depreciation & Amortization | 6↑1.8% | 6↑243.6% | 2↓45.9% | 3↑20.2% | 3 | |
| EBITDA | -53↑18.5% | -64↑13.3% | -74↓36.3% | -55↓14.8% | -47 | |
| EBIT | -59↑16.6% | -71↑7.1% | -76↓31.5% | -58↓15.1% | -50 | |
| Interest & Other Income | ||||||
| Net Interest Income | 8↓27.0% | 11↓14.1% | 13 | 0.00↓100.0% | 0.33 | |
| Interest Income | 8↓27.0% | 11↓14.1% | 13↑115.8% | 6↑1667.8% | 0.33 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 6 | 0.00 | |
| Non-Operating Income | -8↑26.7% | -11 | 0.00↑100.0% | -6↓3011.5% | -0.18 | |
| Other Income / Expenses | 8↓26.7% | 11↓14.3% | 12↑119.1% | 6↑3011.5% | 0.18 | |
| Income Before Tax | -59↑16.6% | -71↓11.2% | -64↓9.9% | -58↓15.1% | -50 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -59↑16.6% | -71↓11.2% | -64↓9.9% | -58↓15.1% | -50 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -59↑16.6% | -71↓11.2% | -64↓9.9% | -58↓15.1% | -50 | |
| Bottom-Line Net Income | -59↑16.6% | -71↓11.2% | -64↓9.9% | -58↓15.1% | -50 | |
| EPS (Basic) | -0.47↑16.1% | -0.56↓9.8% | -0.51↓10.9% | -0.46↑23.3% | -0.60 | |
| EPS (Diluted) | -0.47↑16.1% | -0.56↓9.8% | -0.51↓10.9% | -0.46↑23.3% | -0.60 | |
| Weighted Average Shares | 126↑0.7% | 125↑0.4% | 125↑0.3% | 125↑47.5% | 84 | |
| Weighted Average Diluted Shares | 126↑0.7% | 125↑0.4% | 125↑0.3% | 125↑47.5% | 84 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.